About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 176 record(s)
Req # A-2021-03660
Provide a breakdown of specific dollar totals levied by the PMPRB against pharmaceutical companies in the form of excessive revenue payments. For each excessive revenue payment, break it down by date, company charged, drug in question, and amount levied.Organization: Patented Medicine Prices Review Board Canada
March 2021
Req # A-2021-03662
Copies of all documentation indicating how excessive revenue payments claimed from pharmaceutical companies were handled and how such payments are processed by the PMPRB.Organization: Patented Medicine Prices Review Board Canada
March 2021
Req # A-2020-18437
Copies of all work plans, regulatory processes, consultation processes and departmental reports from June 1, 2020 to November 26, 2020. Include, but do not limit the scope of the request to, documents that detail the internal reporting and operational structure of the PMPRB, emails to/from the PMPRB executive, along with memos, briefing notes, fact sheets, and third party consultations provided to the PMPRB executive.Organization: Patented Medicine Prices Review Board Canada
March 2021
Req # A-2020-00031
Please provide the following statistics: 1. Total number of applications received for a border services officer position with the Canada Border Services Agency in the past 8 years, broken down by: (a) Total number of Canadian citizen applicants (b) Total number of Canadian permanent resident applicants 2. Number of border services officers hired in the past 7 years, broken down by: (a) Number of Canadian citizens hired (b) Number of Canadian permanent residents hiredOrganization: Public Service Commission of Canada
March 2021
Req # A-2020-00032
Please provide me with the following: 1. Total number of applications received for an immigration officer position with Immigration, Refugees and Citizenship Canada in the past 8 years, broken down by: (a) Total number of Canadian citizen applicants (b) Total number of Canadian permanent resident applicants 2. Number of immigration officers hired in the past 8 years, broken down by: (a) Number of Canadian citizens hired (b) Number of Canadian permanent residents hiredOrganization: Public Service Commission of Canada
March 2021
Nothing to report this month
Organization: Canada TMP Finance Ltd.
Req # A-2020-00811
Provide the specific dollar penalties and total claimed by the PMPRB from the use of excessive prices penalty since 2005 and documentation showing what the money was used for.Organization: Patented Medicine Prices Review Board Canada
February 2021
Req # A-2020-00813
Copies of documents related to the use of the excessive price penalty against Alexion Pharmaceuticals.Organization: Patented Medicine Prices Review Board Canada
February 2021
Req # A-2020-14747
Copies of meeting minutes, presentations and speaking notes associated with rare disease drugs from May 1, 2020 to July 31, 2020.Organization: Patented Medicine Prices Review Board Canada
February 2021
Req # A-2020-18436
Provide a detailed disclosure of all third parties consultations over regulation and pricing of new drugs from June 1, 2019 to November 19, 2020, broken down by date, meeting minutes, and summary of meetings.Organization: Patented Medicine Prices Review Board Canada
February 2021